113 results on '"Jagsi, Reshma"'
Search Results
2. A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.
3. Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA
4. ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages
5. Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic
6. Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology Practices
7. ASCO Ethical Guidance for the US Oncology Community Where Reproductive Health Care Is Limited by Law
8. Ethics-Centered Guidelines for Social Media Use by Oncology Professionals: A Call to Action
9. Challenges faced by female oncologists in sub-Saharan Africa.
10. Trainee and program director perspectives of parental leave and parenthood in oncologic specialties.
11. NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer.
12. Radiation Therapy in Older Adults With Cancer: A Critical Modality in Geriatric Oncology
13. Influence of decision support persons on breast cancer treatment decisions among Latinas.
14. Composition of the Current Academic Radiation Oncology Workforce in Comprehensive Cancer Centers
15. Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment
16. Racial Differences in Treatments and Toxicity in Patients With Non–Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy
17. “I'm Being Forced to Make Decisions I Have Never Had to Make Before”: Oncologists' Experiences of Caring for Seriously Ill Persons With Poor Prognoses and the Dilemmas Created by COVID-19
18. Picture a Professional: Rethinking Expectations of Medical Professionalism Through the Lens of Diversity, Equity, and Inclusion
19. Patient Experiences, Trust, and Preferences for Health Data Sharing
20. Sensitivity of Psychosocial Distress Screening to Identify Cancer Patients at Risk for Financial Hardship During Care Delivery
21. Financial Toxicity During Breast Cancer Treatment: A Qualitative Analysis to Inform Strategies for Mitigation
22. ‘I’m being forced to make decisions I have never had to make before’: Oncologists and the conundrums created by COVID-19.
23. OCEAN (wOmen’s Career choicEs About oNcology) Study: Motivations to pursue or not pursue academic oncology.
24. Statewide rates of adjuvant checkpoint inhibitor use after definitive chemoradiation for stage III non-small cell lung cancer.
25. Sexual harassment of oncologists.
26. Factors associated with endowed chair allocation in medical oncology divisions and departments in the United States.
27. Governance of a Learning Health Care System for Oncology: Patient Recommendations
28. Shared decision-making attitudes and practices in multidisciplinary cancer care teams.
29. Initial pilot testing of a smartphone app for detection of chemotherapy-induced peripheral neuropathy.
30. Financial and employment toxicity related to breast reconstruction following mastectomy in a diverse population-based cohort.
31. Patient Preferences Regarding Informed Consent Models for Participation in a Learning Health Care System for Oncology
32. Integration of Breast Reconstruction and Postmastectomy Radiotherapy
33. Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic
34. A comprehensive analysis of the demographics and citation-based productivity of radiation oncologists practicing at comprehensive cancer centers.
35. Socioeconomic Factors Associated With Burnout Among Oncology Trainees
36. Effect of Public Deliberation on Patient Attitudes Regarding Consent and Data Use in a Learning Health Care System for Oncology
37. Nationwide Survey of Patients’ Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences
38. ENRICH: Validating a multidimensional patient-reported financial toxicity measure.
39. Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer
40. Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693).
41. Modeling accrual of older adults to cancer clinical trials: (Alliance A151736).
42. Comparison of Population-Based Observational Studies With Randomized Trials in Oncology
43. Debating the Optimal Approach to Nodal Management After Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
44. Provider Involvement in Care During Initial Cancer Treatment and Patient Preferences for Provider Roles After Initial Treatment
45. The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.
46. Meaningful and Accurate Disclosure of Conflict of Interest at the ASTRO National Meeting: A Need for Reassessment of Current Policies
47. Improving informed breast cancer systemic treatment decision-making.
48. Readability of informed consent forms for cancer patients undergoing radiation therapy: A nationwide survey.
49. Financial toxicity of cancer care: Defining pathways of decline vs resilience.
50. Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.